- Home
- VRCA vs DMA Comparison
VRCA vs DMA Comparison
Compare VRCA & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VRCA | DMA |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | 71 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 76.4M |
| IPO Year | 2018 | 2011 |
Fundamental Metrics
Financial Performance| Metric | VRCA | DMA |
|---|---|---|
| Price | $5.47 | $8.46 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 129.4K | 39.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $372.93 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.39 | $7.17 |
| 52 Week High | $9.82 | $9.15 |
Technical Indicators
Market Signals| Indicator | VRCA | DMA |
|---|---|---|
| Relative Strength Index (RSI) | 34.60 | 36.08 |
| Support Level | $5.34 | $8.25 |
| Resistance Level | $6.44 | $8.82 |
| Average True Range (ATR) | 0.47 | 0.17 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 6.67 | 35.63 |
Price Performance
Historical ComparisonAbout VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.